T1	Participants 37 76	elderly oncologic hypertensive patients
T2	Participants 108 135	Elderly neoplastic patients
T3	Participants 380 420	hypertensive neoplastic elderly patients
T4	Participants 1442 1491	elderly patients under chemotherapeutic treatment
